Impact of COVID-19 on HIV Preexposure Prophylaxis Prescriptions in the United States – A Time Series Analysis -

AbstractBackground. Uptake of HIV preexposure prophylaxis (PrEP) has been increasing in the United States since its FDA approval in 2012; however, the

1484936449573236748

Michael Calderwood, MD, MPH

As if we needed another reason to hate #COVID19. Compared with expected trend, HIV preexposure prophylaxis (PrEP) declined during pandemic - 22% ⬇️ for prescriptions, 25% ⬇️ for new PrEP users. https://t.co/xA7LzstQ5f https://t.co/xA7LzstQ5f - view on twitter

More coverage: #covid19

Read the full article here

See more from Michael Calderwood, MD, MPH